Author： ten Freyhaus Henrik Dumitrescu Daniel Berghausen Eva Vantler Marius Caglayan Evren Rosenkranz Stephan
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.1, 2012-01, pp. : 119-134
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pharmacologic Treatment of Pulmonary Arterial Hypertension
Current Pharmaceutical Design, Vol. 19, Iss. 22, 2013-07 ,pp. :
Access to resources
Recommend
The long-term use of imatinib may be beneficial for patients with pulmonary arterial hypertension
Inpharma, Vol. 1, Iss. 1555, 2006-01 ,pp. :
Targeted Oral Therapies in the Treatment of Pulmonary Arterial Hypertension
Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. :
Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension
By O'Callaghan Dermot S Savale Laurent Yaïïci Azzedine Natali Delphine Jaïïs Xavier Parent Florence Montani David Humbert Marc Simonneau Géérald Sitbon Olivier
Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. :